Evusheld monoclonal antibody against COVID-19 will be officially deployed to people from March 26, 2022
The monoclonal antibody Evusheld has been licensed for circulation in a state of emergency in a number of countries such as the US, France, the United Arab Emirates, Bahrain… Currently, this antibody has also been issued by the Vietnamese Ministry of Health. and Tam Anh General Hospital is the first hospital in Vietnam that is allowed to inject monoclonal antibodies to people.
On March 22, 2022, the system of Tam Anh General Hospital in Hanoi and Tam Anh General Hospital in Ho Chi Minh City. Ho Chi Minh City started receiving information about injection registration.
On March 24, 2022, Tam Anh General Hospital system officially received the first batch of Evusheld monoclonal antibodies from VNVC and AstraZeneca Vietnam Immunization System and will be officially deployed to vaccinate people. from March 26 at Tam Anh General Hospital (Hanoi and Ho Chi Minh City). The hospital will organize injections of monoclonal antibodies against Evusheld on all days of the week, from Monday to Sunday.
Evusheld is the world’s first monoclonal antibody approved by the US Food and Drug Administration (FDA) for the prevention of SARS-CoV-2 virus, especially in high-risk, human populations. The weak, the immunocompromised, the group of people who are not able to produce antibodies despite being vaccinated with a full dose of COVID-19 vaccine, or those who cannot receive the vaccine.
Evusheld monoclonal antibody does not replace the COVID-19 vaccine for the community, but only targets people who are immunocompromised or are unable to have a satisfactory immune response, or do not produce adequate antibodies after vaccination. full dose of vaccine and for people who are unable to receive the vaccine because of a serious adverse reaction to the COVID-19 vaccine.
Law and Readers
at Blogtuan.info – Source: cafebiz.vn – Read the original article here
